Health and Economic Benefits
of Compulsory Regular Vaccination in Slovak Republic. IV. Measles, Rubella and
Mumps
Hudečková H. 1 , Straka Š. 2 , Avdičová M. 3 , Rusňáková Š. 4
1 Odbor epidemiológie, Štátny zdravotný ústav, Martin 2 Ústav epidemiológie, Jesseniova lekárska fakulta Univerzity Komenského, Martin 3 Odbor epidemiológie, Štátny zdravotný ústav, Banská Bystrica 4 Neštátne zdravotnícke zariadenie pre deti a dorast, Martin |
|
Summary:
The epidemiological situation as regards measles, rubella and mumps in Slovakia before vaccination
and after its introduction in 1996, is analysed. On the basis of model costs of treatment of these
diseases before vaccination and costs of treatment in 1996 including costs of vaccination, the authors
calculated the total saved costs (549.7 mil. Sk), cost-effectiveness (10 680 Sk), as well as the
cost-benefit.
Key words:
measles, rubella and mumps vaccination – saved costs – cost-effectiveness – cost-benefit.
|
